Silexion Completes Data Collection Phase in First-Ever Evaluation of SIL-204 in Clinically Relevant Orthotopic Models; ...
DURIPANC is an investigator-initiated, exploratory, open-label, single-center study in the Netherlands at the Erasmus Medical ...
The former Illinois governor has been undergoing chemotherapy after a diagnosis last month, he told the Sun-Times. “I’m ...
For millennials and Gen Z, cancer is no longer rare. Once considered something people get as they grow older, it’s become a ...
Testing is recommended for those with personal and family histories of several types of cancer — including pancreatic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results